); and did not have chronic pulmonary disease. Radiographs showed bilateral pulmonary infi ltrates, and he was hypoxemic. Two weeks previously, the patient had begun receiving therapy for recurrent multiple myeloma (lenalidomide and high-dose dexamethasone). He was intubated at the time of initial visit to the ED for infl uenza symptoms, and broad-spectrum antimicrobial drugs were administered (vancomycin 1,000 mg every 12 h, piperacillin-tazobactam 4.5 gm every 6 h, and levofl oxacin 750 mg 1×/d). Initial nasopharyngeal wash was negative for infl uenza A and B antigen by enzyme immunoassay; serum creatine kinase was 271 U/L (reference range 38-174 U/L).
After oxygenation worsened, bronchoalveolar lavage was performed, and drug therapy was broadened to include voriconazole, trimethoprim-sulfamethoxazole, and prednisone. Bronchoalveolar lavage viral culture was positive for infl uenza A, and real-time reverse transcription-PCR confi rmed pandemic (H1N1) 2009 virus infection. Therapy with oseltamivir (75 mg every 12 h) was initiated, and the patient's respiratory status gradually improved. On hospital day 14, total creatine kinase levels were elevated at 4,854 U/L and rose to 76,015 U/L over the next 4 days before decreasing. Urine myoglobin peaked at 286,000 μg/L (reference range 0-28 μg/L). Renal function remained at baseline until the patient was discharged 2 weeks later; measured glomerular fi ltration rates were >120 mL/min. Hydration with normal saline and supportive care was provided; the patient was extubated and discharged to a rehabilitation hospital on hospital day 19. No medications or other treatments could be implicated as the cause of rhabdomyolysis in this patient.
More commonly reported in children, myositis associated with infl uenza A and B has been well documented and appears to occur most often during the convalescent phase of illness (1). Infl uenza-associated rhabdomyolysis with myoglobinuria have been shown to complicate 3% of cases of myositis in children, are more likely to be associated with infl uenza A infection (1), and have been associated with renal insuffi ciency requiring renal replacement therapy (1, 2) . The frequency of myositis or rhabdomyolysis among adults with pandemic (H1N1) 2009 infection is unclear, but a recently published case series of 18 severely ill patients in Mexico showed that mild to moderate creatine kinase elevation (1,000-5,000 U/L) occurred in >60% of tested patients (3). A report from Australia documented rhabdomyolysis as a complication of pandemic (H1N1) 2009 infection in a 16-yearold-boy (4), and, more recently, a case of rhabdomyolysis was reported in a 28-year-old patient (5).
Our case demonstrates rhabdomyolysis with myoglobinuria that arose during convalescence from severe pandemic (H1N1) 2009 pneumonia in an immunocompromised adult.
It is yet to be determined whether pandemic (H1N1) 2009 virus infection has a higher propensity toward muscular infl ammation than do other viral infections or seasonal infl uenza. Rhabdomyolysis should be considered in the evaluation of muscle symptoms associated with pandemic (H1N1) 2009 virus infection, especially among critically ill patients. When infl uenza suspicion is high, obtaining bronchoalveolar lavage specimens for viral culture, PCR, and antigen testing should be considered if nasopharyngeal sampling and testing for infl uenza antigen and viral culture are initially negative.
